Explain Otezla May Be Safer Than Methotrexate for Plaque Psoriasis

March 2015

A new ORAL med called Otezla (oh-TEZ-luh) will bring up questions about how to treat moderate to severe plaque psoriasis.

About 20% of psoriasis patients need systemic meds added to topicals to manage severe or widespread skin lesions.

Be aware of the extra interactions, side effects, and monitoring.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Vaccines Point Out One Child Will Die for Every 10 That Get Tetanus
Diabetes Think of Forxiga as Similar to Invokana for Type 2 Diabetes
Diabetes Suggest Saving Afrezza for Patients Who Balk at Mealtime Insulin Injections
Women's Health Suggest Saving Opioids for Severe Pain During Pregnancy
Metformin Feel More Comfortable Dispensing Metformin in STABLE Kidney Disease
Gastroenterology Avoid Domperidone in Patients With Heart Disease
Respiratory & Allergy Explain Patients May Have a Bitter Taste After Using Dymista
Psoriasis Explain Otezla May Be Safer Than Methotrexate for Plaque Psoriasis
Eating Disorders Suggest Vyvanse for Adults Who Binge Eat More Than 3 Days Per Week
Readmissions Ask for Discharge Orders to Understand Med Changes During Hospitalization
Kidney Stones Suggest Doxazosin for Kidney Stones if Tamsulosin Isn't an Option